Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "woof_url_parser" was enqueued with dependencies that are not registered: woof_front. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /var/www/vhosts/biomarmt.com/httpdocs/wp-includes/functions.php on line 6170

MISION & VISION

BIOMAR Microbial Technologies is a biotech company founded in 1996, devoted to Marine Microbiology and Natural Products Chemistry

☆ ☆ ☆
Biomar Microbial Technologies building

BIOMAR Microbial Technologies is a biotech company founded in 1996, devoted to Marine Microbiology and Natural Products Chemistry.

Marine biodiversity is assumed to be higher than terrestrial, although marine studies have been under represented for decades due to the technical difficulties in bioprospecting the ocean.

Our goal is to discover, develop and produce new compounds and products of industrial interest.

The company strategic vision relies in two fundamental concepts: INNOVATION AND SUSTAINABILITY.

We offer a unique combination of both products and services based on marine microorganisms and the compounds they produce.

The diversity of our libraries, our team technical excellence and our large experience in the design and performance of research projects, have been the basis of our success in the development of products and processes in three major industrial sectors: Human Health and Cosmetics, Agriculture and Food Industry.

MILESTONES

A beautiful journey full of discoveries

☆ ☆ ☆
2021
New Production Plant

Inauguration of new production plant with capacity of up to 3000L.

2019
Pharmaceutical Sector

Signing of a contract with a leading company in the pharmaceutical sector: animal health products

 
2017
Biopesticides

Recognition to the biopesticides strategic plan from Junta de Castilla y León

 
2016
4D Pharma PLC

Product Development and Production Area transfer to 4D Pharma PLC.

 
2015
Human Health

Human Health reactivation. Adjustment of proceedings to Nagoya Protocol.

 
2014
Valent BioSciences

Extension of Valent BioSciences Corporation contract. Bio-rational products.

2013
Financial Balance

The company fulfils financial balance and profit

 
2012
Cosmetics

Cosmetic Antiacne ingredient reaches the market in collaboration with Infinitec

2011
EPA approval

First Biomar's EPA approved product, herbicide Thaxtomin A.

2010
+Production capacity

Quality Standards and increment of production capacity to 3000 L

2009
New building

We are opening a new building in the León Technology Park.

2008
Foods

Food additives, a new biotechnology sector.

2007
Biodiesel

Identification of Microalgae for biodiesel production.

2006
Share capital increase

First increase in company's share capital.

2005
UE MIRACLE project

UE MIRACLE Project ISolation of uncultured marine microorganism.

2004
Microalgae

First Spanish insdustrial microalgae library.

2003
Human Health

Human Health new therapeutic areas antiagiogenesis and neoroprotection.

2002
New CEO

Dr. Antonio Fernández appointed new CEO.

2001
Production

Production kick off the Fermentation Pilot Plant.

2000
Agriculture

Agrilculture biopesticides, new biotech area. R&D contract with Dupont.

1999
Human Health

Human Health new therapeutic areas antifectives and oncology.

1998
Human Health

Human Health focused on Oftalmology. Colaboration with ONCE.

1997
First bioprospections

Beginning of marine bioprospections that will constitute Biomar Libraries.

1996
Biomar is born

Biomar arises as a spin off of PharmaMar (Grupo Zeltia).

MANAGEMENT

Dr. Antonio Fernández Medarde

Chief Executive Officer

CEO. Antonio got his PhD from the Univerisity of Texas, MD Anderson Cancer Center in Houston where he also did his postdoctoral studies in the Department of Cellular Biology and Molecular Pathology.

After that, he moved to Boston to work as a scientist under the supervision of Dr. Judah Folkman in the Department of Tumor Immunology at the Dana-Farber Cancer Institute and the Children’s Hospital of Boston Surgical Research Laboratories, both associated to Harvard Medical School.

In 2001, he moved back to Spain joining the Research Unit at Hospital de León until February 2002 when he became part of Biomar’s team.

PARTNERS

They already trust us to develop their projects

☆ ☆ ☆

HOW CAN WE HELP YOU?

Researching since 1996

Biomar MT | Producción de compuestos

DO YOU HAVE AN IDEA

WE

...LITERALLY

Biomar counts with 750 m2 fully dedicated to the development of GMP fermentation, with process capacity up to 3000 L. Our scientists’ extensive experience in developing bacterial, fungal and actinomycete fermentations, together with our brand new facilities, guarantee a comprehensive CDMO service. Our plant has all the necessary equipment for process development and optimisation, both upstream and downstream.

Subscribe to our NEWSLETTER

Biomar Microbial Technologies informs you that the personal data that you provide by filling in this form will be processed by Instituto Biomar, S.A. as responsible for this web. Purpose of the collection and processing of personal data: manage registration to this subscription and send periodic newsletters with information and offer perspective products or own services. Legitimation: Consent of the interested party. Rights: You can exercise your rights of access, rectification, limitation and deletion of data at pd@biomarmt.com as well as the right to submit a claim to a control authority. You can consult the additional and detailed information on Data Protection on our website: biomarmt.com, as well as consult our Privacy Policy.